AJP - Renal AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F1535-F1544, 2008. First published September 10, 2008; doi:10.1152/ajprenal.90445.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/F1535    most recent
90445.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saiki, R.
Right arrow Articles by Clarke, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saiki, R.
Right arrow Articles by Clarke, C. F.

Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2

Ryoichi Saiki,1 Adam L. Lunceford,1 Yuchen Shi,1 Beth Marbois,1 Rhonda King,2 Justin Pachuski,2 Makoto Kawamukai,3 David L. Gasser,2 and Catherine F. Clarke1

1Department of Chemistry and Biochemistry and the Molecular Biology Institute, University of California, Los Angeles, California; 2Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and 3Department of Life Science and Biotechnology, Shimane University, Matsue, Japan

Submitted 30 July 2008 ; accepted in final form 7 September 2008

Homozygous mice carrying kd (kidney disease) mutations in the gene encoding prenyl diphosphate synthase subunit 2 (Pdss2kd/kd) develop interstitial nephritis and eventually die from end-stage renal disease. The PDSS2 polypeptide in concert with PDSS1 synthesizes the polyisoprenyl tail of coenzyme Q (Q or ubiquinone), a lipid quinone required for mitochondrial respiratory electron transport. We have shown that a deficiency in Q content is evident in Pdss2kd/kd mouse kidney lipid extracts by 40 days of age and thus precedes the onset of proteinuria and kidney disease by several weeks. The presence of the kd (V117M) mutation in PDSS2 does not prevent its association with PDSS1. However, heterologous expression of the kd mutant form of PDSS2 together with PDSS1 in Escherichia coli recapitulates the Q deficiency observed in the Pdss2kd/kd mouse. Dietary supplementation with Q10 provides a dramatic rescue of both proteinuria and interstitial nephritis in the Pdss2kd/kd mutant mice. The results presented suggest that Q may be acting as a potent lipid-soluble antioxidant, rather than by boosting kidney mitochondrial respiration. Such Q10 supplementation may have profound and beneficial effects in treatment of certain forms of focal segmental glomerulosclerosis that mirror the renal disease of the Pdss2kd/kd mouse.

ubiquinone; mitochondrial lipid metabolism; genetic renal disease; focal segmental glomerulosclerosis; antioxidant



Address for reprint requests and other correspondence: C. F. Clarke, UCLA Dept. of Chemistry and Biochemistry, 607 Charles E. Young Dr. E., Los Angeles, CA 90095-1569 (e-mail: cathy{at}chem.ucla.edu)




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
E. Machuca, G. Benoit, and C. Antignac
Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology
Hum. Mol. Genet., October 15, 2009; 18(R2): R185 - R194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.